Li Liang
8PUBLICATIONS
11CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Oct 15, 2024
Nivolumab plus anlotinib hydrochloride in advanced gastric adenocarcinoma and esophageal squamous cell carcinoma: the phase II OASIS trial.Jing Wu, Shilong Zhang, Shan Yu
|Aug 23, 2024
Tislelizumab plus cetuximab and irinotecan in refractory microsatellite stable and RAS wild-type metastatic colorectal cancer: a single-arm phase 2 study.Xiaojing Xu, Luoyan Ai, Keshu Hu
|Apr 27, 2024
Identification of Novel Tumor Pyroptosis-Related Antigens and Pyroptosis Subtypes for Developing mRNA Vaccines in Pancreatic Adenocarcinoma.Qiaowei Lin, Li Liang, Qing Wang
|Sep 21, 2022
Heparanase modulates the prognosis and development of BRAF V600E-mutant colorectal cancer by regulating AKT/p27Kip1/Cyclin E2 pathway.Mengling Liu, Xiaojing Xu, Ke Peng
|Mar 15, 2022
An integrated bioinformatic investigation of mitochondrial solute carrier family 25 (SLC25) in colon cancer followed by preliminary validation of member 5 (SLC25A5) in tumorigenesis.Yan-Jie Chen, Wei-Feng Hong, Meng-Ling Liu
|Feb 04, 2022
IRF-2 inhibits cancer proliferation by promoting AMER-1 transcription in human gastric cancer.Yan-Jie Chen, Shu-Neng Luo, Hao Wu
Pageof 2
